Goosehead Insurance Plans Financial Restatement
GSHD sits 62% above its 52-week low of $33.68.
Summary
Goosehead says it plans to restate its financial statements for 2023, 2024 and 2025 and the first two quarters of 2026, a disclosure that puts prior reported results back in question. The restatement stems from accounting for certain costs to obtain customer contracts that didn't conform to GAAP: certain commissions paid to obtain contracts were expensed within employee compensation and benefits rather than deferred and amortized over the period of expected benefit. The company has delayed its 10-Q filing. For 2025, Goosehead expects both total revenue and general and administrative expenses to increase by equivalent amounts of about $11M-$16M. The restatement comes after a stretch of insider selling by the founding Jones family and affiliated trusts, followed by Durable Capital's $7.1 million purchase in September, and the company had been reporting strong revenue growth with an active buyback, so any revision to those figures hits the core thesis. Goosehead has also released preliminary third quarter 2026 results.
At the time of this announcement, GSHD was trading at $54.69 on NASDAQ in the Finance sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $33.68 to $79.85. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.